Key facts
- Alginor’s last known valuation is $101.1M (Jun 2024).
- It has raised $300.4M; the latest was Debt - General ($23.1M) in Oct 2025.
- Notable investors include European Innovation Council, Must Invest, Profond (Norway), AMAR INVEST I, BNP Paribas — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Alginor
- ·The full record, as it builds
Funding rounds
No funding rounds for Alginor are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alginor
Manufacturer of kelp-based life science ingredients intended to offer sustainable materials. The company harvests and biorefines Laminaria Hyperborea to offer mannitol, fucoidan, cellulose, alginate, oligosaccharides, polyphenols, carotenoids, amino acids, savory, laminarin, biobased materials, and borea powder, enabling companies to produce without downstream waste and zero formaldehyde.
- Sector
- Business Products and Services (B2B)
- HQ
- Avaldsnes, Norway
- Founded
- 2014
- Employees
- 50
- Website
- alginor.no/
- Ownership
- Privately Held (backing)
Alginor doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alginor shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alginor in its N-PORT filings yet. We sweep new filings monthly.